Cochrane Evidence Synthesis and Methods ►

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

This is a protocol.

Health topics:

Urology > Benign prostatic hyperplasia

Published:

4 November 2015

Authors:

García-Perdomo HA, Lopez HE, Tacklind J

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
García-Perdomo HA, Lopez HE, Tacklind J. 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD011928. DOI: 10.1002/14651858.CD011928